Core Insights - Aemetis reported a quarterly loss of $0.37 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.25, marking an earnings surprise of -48.00% [1] - The company generated revenues of $59.19 million for the quarter ended September 2025, missing the Zacks Consensus Estimate by 35.56% and down from $81.44 million a year ago [2] - Aemetis shares have declined approximately 23.4% year-to-date, contrasting with the S&P 500's gain of 15.6% [3] Earnings Outlook - The future performance of Aemetis stock will largely depend on management's commentary during the earnings call and the company's earnings outlook [4] - The current consensus EPS estimate for the upcoming quarter is -$0.25 on revenues of $103.1 million, and for the current fiscal year, it is -$1.36 on revenues of $300.3 million [7] Industry Context - The Biofuels industry, to which Aemetis belongs, is currently ranked in the top 2% of over 250 Zacks industries, indicating a favorable outlook for stocks within this sector [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked using tools like the Zacks Rank [5][6]